Next Article in Journal
Efficacy and Safety of Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Combination Therapy as First-Line Treatment for Patients with Advanced EGFR-Mutated, Non-Small Cell Lung Cancer: A Systematic Review and Bayesian Network Meta-Analysis
Next Article in Special Issue
Chimeric Antigen Receptor Immunotherapy for Solid Tumors: Choosing the Right Ingredients for the Perfect Recipe
Previous Article in Journal
Histological Subtypes Drive Distinct Prognostic Immune Signatures in Classical Hodgkin Lymphoma
Previous Article in Special Issue
Overcoming the Impact of Hypoxia in Driving Radiotherapy Resistance in Head and Neck Squamous Cell Carcinoma
 
 
Review

Article Versions Notes

Cancers 2022, 14(19), 4888; https://doi.org/10.3390/cancers14194888
Action Date Notes Link
article xml file uploaded 6 October 2022 13:45 CEST Original file -
article xml uploaded. 6 October 2022 13:45 CEST Update https://www.mdpi.com/2072-6694/14/19/4888/xml
article pdf uploaded. 6 October 2022 13:45 CEST Version of Record https://www.mdpi.com/2072-6694/14/19/4888/pdf
article html file updated 6 October 2022 13:46 CEST Original file -
article html file updated 28 February 2023 16:53 CET Update -
article html file updated 1 March 2023 15:21 CET Update https://www.mdpi.com/2072-6694/14/19/4888/html
Back to TopTop